RE:RE:RE:RE:Financials are out on SedarThanks for the recap Enriquesuave.
enriquesuave wrote: Yes that's Q1 and results look amazing to me. So far 7 patients out of 22 are CR at both 3 months and maintained at 6 months.( that's 2 from PH1 and 5 from PH2).. Also 2 PR or partial responses are still PR at 6 months ( indicating they have a clean cystoscope exam and only urine cytology is positive), which is also amazing as there is a good chance that they have UUTUC rather than bladder cancer and may eventually be counted as CR. 4 patients are still pending 90 and 180 days so numbers can go up. Given that 5 patients were wrongly dropped from trial early on given severe underdosing of 1st 12 patients, results look pretty awesome I would say. We see high efficacy and a durable efficacy. None of the competitors show the same durable efficacy from 3 months to 6 months all drop from about 45% to 30% and drop further to 15-24% at 12 months and even further at 450 days. This awesomeness should be confirmed after we see data from pending patients IMO.